When the novel coronavirus COVID-19 first appeared in late December 2019, scientists at the Yale School of Public Health responded immediately to help shape the world’s public health response. Our experts in transmission, genetics, vaccines, social behaviors, modeling, health policy and global health and justice not only have been at the forefront of scientific discovery, but they have made it a priority to inform the public through media appearances, op-ed pieces, consulting, town halls and other forums.
As this historic pandemic has unfolded in real time, our work at the Yale School of Public Health has never been more relevant or impactful. Our global influence has taken the form of research, public education and public service.
On August 15, 2020, the FDA authorized YSPH to officially designate qualified CLIA-certified laboratories to run the SalivaDirect™ Test. Since then, 405 laboratories have requested designation under our emergency use authorization (EUA). As of January 30, 2021, we have initiated the designation process with 318 of these laboratories and streamlined the designation process so that it now takes on average 3-5 days from the time a laboratory submits all required documentation and CLIA verification data.